KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Cash from Financing Activities (2016 - 2026)

Medtronic (MDT) has disclosed Cash from Financing Activities for 13 consecutive years, with -$2.1 billion as the latest value for Q1 2026.

  • Quarterly Cash from Financing Activities fell 19.05% to -$2.1 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$5.2 billion through Jan 2026, up 3.18% year-over-year, with the annual reading at -$4.4 billion for FY2025, 2.0% up from the prior year.
  • Cash from Financing Activities hit -$2.1 billion in Q1 2026 for Medtronic, down from -$395.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $3.0 billion in Q4 2022 to a low of -$4.9 billion in Q2 2023.
  • Historically, Cash from Financing Activities has averaged -$1.2 billion across 5 years, with a median of -$1.3 billion in 2025.
  • Biggest five-year swings in Cash from Financing Activities: soared 360.95% in 2022 and later crashed 493.33% in 2024.
  • Year by year, Cash from Financing Activities stood at $3.0 billion in 2022, then plummeted by 102.99% to -$90.0 million in 2023, then plummeted by 493.33% to -$534.0 million in 2024, then grew by 26.03% to -$395.0 million in 2025, then tumbled by 428.35% to -$2.1 billion in 2026.
  • Business Quant data shows Cash from Financing Activities for MDT at -$2.1 billion in Q1 2026, -$395.0 million in Q4 2025, and -$1.4 billion in Q3 2025.